Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
MedImmune Replies to FDA Complete Response Letter on Motavizumab
-
AstraZeneca To Acquire Infection Research Company Novexel And Expand Collaboration With Forest Laboratories
-
Favourable Vote From FDA Advisory Committee On Benefit/Risk Of CRESTOR In JUPITER Study
-
Advisory Committee Briefing Materials For Crestor sNDA Available On US FDA Web Site
-
US FDA Approves Seroquel For The Paediatric Treatment Of Schizophrenia And Bipolar Mania
-
US FDA Approves Seroquel XR For Add-On Treatment Of Major Depressive Disorder
-
AstraZeneca and Targacept Form Global Collaboration and Licence Agreement for Late-Stage Investigational Product TC-5214 for the Treatment of Major Depressive Disorder
-
AstraZeneca Submits US New Drug Application for Brilinta (Ticagrelor), an Investigational Antiplatelet Agent
-
Results from Two Phase II Trials Add to Understanding of Brilinta (Ticagrelor) and How it Works in the Body
-
BRILINTA Demonstrated Greater Efficacy Over Clopidogrel in the Most Urgent Clinical Setting: Patients with ST-Segment Elevation Myocardial Infarction and Planned Percutaneous Coronary Intervention (PCI)
Latest articles and press releases
All of our latest press releases and articles are available to explore
